Drug Type Mesenchymal stem cell therapy |
Synonyms Skin disorder specific amniotic mesenchymal stem cell therapy (Amniotics) |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Burns | Preclinical | SE | 30 Apr 2024 | |
Epidermolysis Bullosa | Preclinical | SE | 30 Apr 2024 | |
Skin injury | Preclinical | SE | 30 Apr 2024 |